Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
Michal Miroslaw FarkowskiAleksander MaciagMalgorzata ZurawskaIlona KowalikHanna SzwedMariusz PytkowskiPublished in: Cardiovascular therapeutics (2018)
In selected patients with a stable CAD, even with a history of MI, antazoline-based CV of short-duration AF may be an effective and safe therapeutic option.
Keyphrases
- atrial fibrillation
- coronary artery disease
- emergency department
- percutaneous coronary intervention
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- cardiovascular events
- coronary artery bypass grafting
- stem cells
- type diabetes
- cardiovascular disease
- bone marrow